Mark McDonough

Mark brings over 22 years of experience in Healthcare diagnostics. He comes to OncoCell from Phosphorus, a genomic software solutions provider, where he served as the Chief Business Officer and remains an Advisor. Prior to Phosphorus, Mark was CEO and President of CombiMatrix, a publicly held molecular diagnostics company performing DNA-based testing services for reproductive health and developmental disorders, and led the company to and through its acquisition by Invitae Corp. Before CombiMatrix, Mark held executive and management positions with US LABS (acquired by LabCorp), Ventana Medical Systems (acquired by Roche), and Pathwork Diagnostics.